Blocking of IL‐22 or ILCs by anti‐Thy1 antibody reduces colorectal cancer.155 IL‐22 can also be regulated by an endogenous mechanism, namely by the decoy IL‐22BP. The gene discussed is IL22; the disease is colorectal cancer.